Search
Menu
Meadowlark Optics - SEE WHAT

Investment Aids Computerized Thermal Imaging's Tests

Facebook X LinkedIn Email
OGDEN, Utah, March 10 -- Computerized Thermal Imaging, Inc. (CTI) will receive an equity investment of $7 million from Beach Boulevard, LLC, which will allow the developer of thermal-imaging medical technologies to complete ongoing clinical trials. CTI is testing the efficacy of its technology, when used in conjunction with clinical examination and/or mammography, to increase physicians' ability to differentiate benign and malignant tissue when examining suspicious breast abnormalities. Preliminary test results indicate that the system may be able to decrease the number of benign biopsies performed by as much as 38%.
Deposition Sciences Inc. - Difficult Coatings - MR-8/23

Published: March 1999
News & Features

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.